Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It works on 3 receptors that are involved in glucose metabolism and appetite regulation: glucagon-like peptide-1 (GLP-1) receptor, glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Current GLP-1 Weight Loss Drugs Compared to GLP-1 medications like semaglutide or dual agonists like tirzepatide, Retatrutides triple-receptor activation may provide: Greater total body weight reduction Increased energy expenditure Enhanced metabolic improvements Broader hormonal targeting This positions it as one of the most promising investigational obesity treatments currently in development
Final Thoughts Ipamorelin stimulates the release of natural growth hormones
Serving size is 1 Tbsp (15 M L), with 31 servings per container and $0.97 per serving
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
US$ 20.41
US$ 28.30
US$ 29.69
US$ 21.05
US$ 23.77
